Ananda Pharma Confirms Safety of CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
24 results for “safety”
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
While CBD is generally considered to be safe, new animal studies have shown alterations in brains and behaviour in offspring exposed to the cannabinoid during pregnancy. The International Cannabis Policy […]
The UK’s Food Standards Agency (FSA) has issued the first two ‘positive safety assessments’ for CBD (cannabidiol) products as part of its years-long novel foods authorisation process. Chanelle McCoy’s subsidiary, […]
The findings have cast doubt over any potential expansion of the Medical Cannabis Access Programme (MCAP).
The ‘legal high’ Hexahydrocannabinol, better known as HHC, is on the rise across Europe. Here’s what you need to know.
The findings build on existing evidence that orally-ingested CBD is safe and non-toxic.
Findings suggest that CBD and THC are safe for use with opioid pain medication.
A new patient network, NOPAIN has been set up with the aim of uniting patients to discuss issues surrounding safe, legal cannabis access.
A second batch of major CBD brands have signed up to participate in the first large-scale study into the safety of the cannabinoid. US research body, Validcare, has announced a […]
Researchers have called for better regulation of CBD e-liquids after examining the prevalence of harmful substances in products. European research company Fundación Canna insists that better regulation is needed in […]
The European Industrial Hemp Association (EIHA) has launched the largest human trial on the toxicological effects of trace amounts of THC in food products – but will it be enough […]
Introducing The Medical Cannabis Employer Handbook
France’s medical cannabis experiment showed treatment was effective in reducing opioid use across four indications.
We take a closer look at the data behind medical cannabis prescribing to examine what it can reliably show us.
Clinicians, scientists and patients explored whether medical cannabis could help address longstanding inequalities in women’s health.
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
The former heavyweight boxing contender revealed he is using prescribed medical cannabis to manage chronic pain.
Inspectors found breaches in care, governance, and oversight at a private medical cannabis clinic.
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
Dr Sue Clenton, Medical Director at Releaf Cannabis Clinic, shares her insight from the frontline of an emerging field of medicine.
Less than 100 patients have been approved for medical cannabis treatment under the MCAP scheme.
A small pilot study suggests Epidiolex may have benefits for weight restoration and symptom improvement in anorexia patients.
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
By Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf […]